Alnylam
Cardiometabolic Therapeutics · Rare Disease Therapeutics

Alnylam news and milestones

Alnylam: 18 headlines on record, 12 headlines in the last 90 days. Its story counts 1 milestone.

Data updated Nov 15, 2026 · Back to the company report
18Headlines
12In 90 days
1Milestones

Headlines

Sep 272026
Sep 202026
Sep 202026
News · YahooFinance
Alnylam Highlights AMVUTTRA Momentum, Resets 2026 TTR Revenue Outlook
Alnylam Pharmaceuticals (NASDAQ:ALNY) highlighted continued momentum for its AMVUTTRA treatment in transthyretin-mediated cardiomyopathy, while outlining a pipeline of upcoming c…
Sep 142026
Blog
Working at alnylam slideshow 2
Working at alnylam slideshow 2 hmotawe Mon, 09/14/2026 - 13:43 div class="field field--name-field-b...
Sep 142026
Blog
Working at alnylam slideshow 4
Working at alnylam slideshow 4 hmotawe Mon, 09/14/2026 - 13:42 div class="field field--name-field-backgroun...
Sep 142026
Blog
Working at alnylam slideshow 1
Working at alnylam slideshow 1 hmotawe Mon, 09/14/2026 - 13:37 div class="field field--name-f...
Sep 142026
Blog
Working at alnylam slideshow 0
Working at alnylam slideshow 0 hmotawe Mon, 09/14/2026 - 13:35 div class="field field--name...
Sep 142026
Blog
Career 4th Slide
Career 4th Slide hmotawe Mon, 09/14/2026 - 13:34 div class="field field--name-field-back...
Sep 142026
Blog
Career third Slide
Career third Slide hmotawe Mon, 09/14/2026 - 13:34 div class="field field--name-field-background-mobile...
Sep 142026
Blog
Career second Slide
Career second Slide hmotawe Mon, 09/14/2026 - 13:32 div class="field field--name-field-background-mobile-...
Sep 142026
Blog
Career Slide show
Career Slide show hmotawe Mon, 09/14/2026 - 13:31 div class="field field--name-field...
Aug 302026
May 132026
Blog
2026 Alnylam 2030 strategy announced
2026 Alnylam 2030 strategy announced hmotawe Wed, 05/13/2026 - 16:15 2026 #fff div class="field field--name-field-timeline-description field--type-text-lon...
Jan 282026
News · The Motley Fool
Should You Buy Alnylam Pharmaceuticals Before Feb. 12?
Alnylam could have a catalyst on the way.
Aug 1, 20252025
May 1, 20252025
Nov 14, 20242024
News · law360
Alnylam Says It's Not A 'Patent Troll' In Vax IP Row
Alnylam Pharmaceuticals has shot back at Moderna's request for about $2.8 million in legal costs it incurred defending a patent suit over its coronavirus vaccine, saying Moderna…
Sources: the outlets named on each headline, each story once

Milestones

2002
Founded
Each milestone is dated by its source: registers, filings, the press

How to cite

Alnylam, News. Alion, Nov 15, 2026. https://alion.io/company/alnylam/news

.json · .md · CC BY-SA 4.0